HealthFLD, a fully automated AI software for liver attenuation analysis from CT scans, has received FDA 510(k) clearance for use in the general population.
Stephen Harrison, MD, provides insight into the use of resmetirom for NASH with fibrosis ahead of the thyroid hormone receptor-β selective agonist’s March 14 PDUFA date.
Results also presented during late-breaking session at ESC Heart Failure congress 2023 ZURICH, SWITZERLAND, May 22, 2023 - (ACN Newswire) - Neurimmune announced today that primary results of its Phase 1 proof-of-concept study of NI006, a recombinant .
acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.